Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 5, 1997, Pages 332-340

  Podell, Michael ^a   Hayes, Kathleen ^a   Oglesbee, Michael ^a   Mathes, Lawrence ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

AIDS; CD4 CD8 lymphocyte ratio Cat; Electroencephalography; Encephalopathy; Evoked potentials; Feline immunodeficiency virus; HIV 1

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CAT; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; FELINE IMMUNODEFICIENCY VIRUS; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030661968     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708150-00002     Document Type: Article

References (63)

1. Ho DD, Bredesen DE, Vinters HV, Daar ES. The acquired immunodeficiency syndrome (AIDS) dementia complex. Ann Intern Med 1989;111:400-10.
2. Belman A. Neurologic syndromes. In: Lyman WD, Rubinstein A, eds. Pediatric AIDS: Clinical, parhologic, and basic science perspectives, vol 693. New York: Annals of the New York Academy of Sciences, 1993:107-22.
3. Janssen RS. Epidemiology of human immunodeficiency virus infection and the neurologic complications of the infection. Semin Neurol 1992;12:10-7.
4. Brew BJ, Sidtis J, Petito CK, et al. The neurologic complications of AIDS and human immunodeficiency virus infection. In: Plum F, ed. Advances in contemporary neurology. Philadelphia: FA Davis, 1988:1-49.
5. Pantaleo GP, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328: 327-35.
6. Cho ES, Sharer LR. HIV encephalopathy in children. In: Kozlowski PB, Snider DA, Vietze PM, Wisniewski HM, eds. Brain in pediatric AIDS. Basel: S. Karger, 1990:158-64.
7. Shearer WT, Rosenblatt HM, Schluchter MD, et al. Immunologic targets of HIV infection: T cells. In: Lyman WD, Rubinstein A, eds. Pediatric AIDS: Clinical, pathologic, and basic science perspectives, vol 693. New York: NY Academy of Sciences, 1993: 35-51.
8. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg 1985; 62:475-95.
9. Dal Pan GJ, McArthur JC, Harrison MJG. Neurological symptoms in human immunodeficiency virus infection. In: Berger JR, Levy RM, eds. AIDS and the nervous system. Philadelphia: Lippincott-Raven Publishers, 1997:141-72.
10. Podell M, Oglesbee M, Matties L, Krakowka S, Olmstead R, Lafrado L. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J Acquir Immune Defic Syndr 1993;6:758-71.
11. King NW. Simian models of acquired immunodeficiency syndrome (AIDS). Vet Pathol 1986;23:345-53.
12. Gardner MB. Neurotropic retroviruses of wild mice and macaques. Ann Neural 1988;23(suppl):S201-6.
13. Narayan O, Cork LC. Lentiviral diseases of sheep and goats: Chronic pneumonia, leukoencephalomyelitis and arthritis. Rev Infect Dis 1987;7:89-98.
14. Gardner MB, Luciw PA. Animal models of AIDS. FASEB J 1989; 3:2593-606.
15. Lafrado LJ, Podell M, Krakowka S, Hayes KA, Hanlon MA, Mathes LE. FIV: A model for retrovirus-induced pathogenesis. In: Koff WC, Wong-Staal F, Kennedy RC, eds. AIDS Res Rev 1993; 3:115-50.
16. Philips TR, Prospero-Garcia O, Puaoi DL, et al. Neurologic abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 1994;75:979-87.
17. Prospero-Garcia O, Herold N, Phillips T, Elder JH, Bloom FE, Henriksen SJ. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci USA 1994;91: 12947-51.
18. Hanlon MA, Marr JM, Hayes KA, et al. Loss of neutrophil and natural killer cell function following feline immunodeficiency virus infection. Virol Immunol 1994;6:119-24.
19. Dow SW, Poss ML, Hoover EA. Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr 1990;3: 658-68.
20. Hurtrel M, Ganiere JP, Guelfi JF, et al. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 1992; 6:399-406.
21. Olmsted RA, Langley R, Roelke ME, et al. Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J Virol 1992;66:6008-18.
22. Hayes KA, Lafrado LJ, Erickson JG, Marr JM, Mathes LE. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats. J Acquir Immune Defic Syndr 1993;6:127-34.
23. Tochikura TS, Hayes KA, Cheney CM, et al. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells. Virology 1990;179:492-7.
24. Sorjonen DC, Golden DL, Levesque DC, Shores A, Moore MP. Cerebrospinal fluid protein electrophoresis: A clinical evaluation of a previously reported diagnostic technique. Prog Vet Neural 1991;2:261-7.
25. Hayes KA, Lafrado LJ, Ericson JG, Marr JM, Mathes LE. Prophylactic AZT therapy prevents early viremia and leucocyte decline but not primary infection in feline immunodeficiency inoculated cats. JAIDS 1993;6:127-34.
26. Sims M, Selcer R. Somatosensory-evoked and spinal cord-evoked potentials in response to pudendal and tibial nerve stimulation in cats. Am J Vet Res 1989;50:542-5.
27. Klüver H, Barrera E. Method for combined staining of cells and fibers in nervous system. J Neuropathol Exp Neural 1953;12: 400-3.
28. Daniel WW. Biostatistics: A foundation for analysis in the health sciences. New York: John Wiley and Sons, 1987:576-630.
29. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
30. Berger JR, Moskowitz L, Fischl M, Kelley RE. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 1987;80:683-6.
31. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price R. HIV infection and the nervous system: Report from the American Academy of Neurology Task Force. Neurology 1989;39:111-22.
32. Koralnik IJ, Beaumanoir A, Hausler R, et al. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med 1990;323:864-70.
33. Moglia A, Zandrini C, Alfonsi E, Rondanelli G. Neurophysiological markers of central and peripheral involvement of the nervous system in HIV-intection. Clin Electroencephalogr 1991;22:193-8.
34. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Pass RJ. Duration of illness and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci 1994;6: 160-4.
35. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986;78:678-87.
36. Rosenhall U, Hakansson C, Lowhagen GB, Hanner P, Jonsson EB. Otoneurological abnormalities in asymptomatic HIV-seropositive patients. Acta Neural Scand 1989;79:140-5.
37. Seines OA, Galai N, Bacellar H, et al. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 1995;45:267-75.
38. Baldeweg T. Gruzelier JH, Catalan J, et al. Auditory and visual event-related potentials in a controlled investigation of HIV infection. Electroencephalogr Clin Neurophysiol 1993;88:356-68.
39. Connolly S, Manji H, McAllister RH, et al. Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infection. Ann Neural 1994;35:189-96.
40. Frank Y, Pahwa S. Serial brainstem auditory evoked responses in infants and children with AIDS. Clin Electroencephalogr 1993;24: 160-5.
41. Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-3.
42. Jabbari B, Coats M, Salazar A, Martin A, Scherokman B, Laws WA. Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects. Electroencephalogr Clin Neurophysiol 1993;86:145-51.
43. Pagano MA, Cahn PE, Garau ML, et al. Brain-stem auditory evoked potentials in human immunodeficiency virus-seropositive patients with and without acquired immunodeficiency syndrome. Arch Neural 1992;49:166-9.
44. Iragui VJ, Kalmijn J, Thai LJ, Grant I. Neurological dysfunction in asymptomatic HIV-1 infected men: Evidence from evoked potentials. HNRC Group. Electroencephalogr Clin Neurophysiol 1994; 92:1-10.
45. Itil TM, Ferracuti S, Freedman AM, Sherer C, Mehta P, Itil KZ. Computer-analyzed EEG (CEEG) and dynamic brain mapping in AIDS and HIV related syndrome: a pilot study. Clin Electroencephalogr 1990;21:140-4.
46. Parisi A, Di PG, Strosselli M, Nappi G, Minoli L, Rondanelli EG. Usefulness of computerized electroencephalography in diagnosing, staging and monitoring AIDS-dementia complex. AIDS 1989;3: 209-13.
47. Nuwer M. Quantitative EEG. II. Frequency analysis and topographic mapping in clinical settings. J Clin Neurophvsiol 1988;5: 45-85.
48. Gradon JD, Timpone JG, Schnittman SM. Emergence of unusual opportunistic pathogens in AIDS: a review. Clin Infect Dis 1992; 15:134-57.
49. Grassi MP, Perin C, Clerici F. Zocchetti C, Cargnel A, Mangoni A. Neuropsychological performance in HIV-1-infected drug abusers. Acta Neural Scand 1993;88:119-22.
50. Harden CL, Daras M, Tuchman AJ, Koppel BS. Low amplitude EEGs in demented AIDS patients. Etectroencephalogr Clin Neurophysiol 1993;87:54-6.
51. Ito BM, Sato S, Kufta LV, Tran D. Effect of isoflurane and enflurane on the electrocorticogram of epileptic patients. Neurology 1988;38:924-8.
52. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neural 1992; 32:658-66.
53. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann Neural 1993;34:339-50.
54. Singer EJ, Syndulko K, Fahy CB, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994;7:265-71.
55. Price RW. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: Introduction. J Neuro-AIDS 1996;1:1-30.
56. Kure K, Lyman W, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS-encephalitis using an improved double-labeling immunohistochemical method. Am J Physiol 1990;136:1085-92.
57. Vazeux R, Lacroix CC, Blanche S, et al. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol 1992;140:137-44.
58. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neural 1986;19:525-35.
59. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992;255:1246-9.
60. Dow SW, Dreitz MJ, Hoover EA. Feline immunodeficiency virus neurotropism: Evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol 1992;35:23-35.
61. Zenger E. Laser cytometric analysis of FIV-induced injury in astroglia. Glia 1995;13:92-100.
62. Abramo F, Bo S, Canese G, Poli A. Regional distribution of lesions in the central nervous system of cats infected with feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995;11:1247-53.
63. Sinclair E, Scaravilli F. Detection of HIV proviral DNA in cortex and white matter of AIDS brains by non-isotopic polymerase chain reaction: Correlation with diffuse poliodystrophy. AIDS 1992;6: 925-32.